*Actor Portrayal

DELAYING PAH
PROGRESSION

STARTS
WITH YOU

STARTS WITH YOU

STOP AT NOTHING

UPTRAVI was proven safe in the LARGEST ADULT TRIAL of any FDA-approved PAH treatment and has ten years of safety data (the longest follow-up period of any PAH therapy).
UPTRAVI SIDE EFFECTS WERE LESS FREQUENT AFTER THE DOSE ADJUSTMENT PHASE (ALSO CALLED TITRATION)
Side effects occurring more frequently for adult patients on UPTRAVI compared to patients on placebo (sugar pill) are headache, diarrhea, jaw pain, nausea, muscle pain, vomiting, pain in arms or legs, temporary reddening of the skin (flushing), joint pain, low red blood cell count, less appetite than usual, and rash.
how to
take UPTRAVI
Taking UPTRAVI with food may help you tolerate UPTRAVI better.

Tell your family and friends that you are starting UPTRAVI and may need their assistance and support.

Always tell your doctor about any side effects, and do not change doses on your own. If you experience side effects that you cannot tolerate, your doctor may lower your dose in order to find your personal dose.


Do not stop taking your medication unless your doctor tells you to stop.
UPTRAVI is the #1 most-prescribed oral prostacyclin pathway therapy in PAH nationwide
Based on yearly prescription and refill data from US claims as of 6/23 and 3/23.

*Actor Portrayal

PAH STOPS AT NOTHING
SHOW IT YOU WON’T EITHER
Yellow play button

Watch the video

*Actor Portrayal

TAKE YOUR TREATMENT PLAN ONE STEP FURTHER